10x Genomics, Inc. (TXG) Ownership
TXG ownership summary
as of October 18, 2026- Institutions
- 117.3% of shares outstanding
- Insiders
- 1.44% of shares outstanding
- Shares outstanding
- 120.2M
- Float
- 118.2M shares available to trade
- Short interest
- 17.30% 15.4M shares short
- Days to cover
- 5.24 short interest down 7.9% vs prior month
- Institutions 117.34%
- Insiders 1.44%
TXG top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | FMR Inc | 13.53% | 17.6M | $1.23B | −111,706 (−0.6%) | June 30, 2026 |
| 2 | BlackRock Inc | 8.29% | 10.8M | $754.8M | +724,157 (+7.2%) | June 30, 2026 |
| 3 | ARK Investment Management LLC | 7.68% | 10.0M | $698.8M | −1.7M (−14.6%) | June 30, 2026 |
| 4 | Vanguard Portfolio Management, LLC | 5.36% | 7.0M | $487.8M | +69,556 (+1.0%) | June 30, 2026 |
| 5 | Quantinno Capital Management LP | 4.20% | 5.5M | $382.1M | +57,937 (+1.1%) | June 30, 2026 |
| 6 | Vanguard Capital Management, LLC | 3.90% | 5.1M | $355.1M | −186,992 (−3.5%) | June 30, 2026 |
| 7 | T. Rowe Price Associates, Inc. | 3.48% | 4.5M | $317.1M | +4.4M (+2,681.0%) | June 30, 2026 |
| 8 | Sumitomo Mitsui Trust Group Inc | 3.22% | 4.2M | $293.0M | −915,587 (−17.9%) | June 30, 2026 |
| 9 | Amova Asset Management Americas, Inc | 3.22% | 4.2M | $292.9M | −911,661 (−17.9%) | June 30, 2026 |
| 10 | Morgan Stanley - Brokerage Accounts | 2.57% | 3.4M | $234.2M | +695,558 (+26.2%) | June 30, 2026 |
| 11 | The Goldman Sachs Group Inc | 2.42% | 3.1M | $220.0M | −822,941 (−20.7%) | June 30, 2026 |
| 12 | Geode Capital Management, LLC | 2.37% | 3.1M | $215.4M | +178,562 (+6.1%) | June 30, 2026 |
| 13 | State Street Corp | 2.15% | 2.8M | $195.7M | +212,642 (+8.2%) | June 30, 2026 |
| 14 | Citadel Advisors Llc | 2.13% | 2.8M | $194.2M | +2.0M (+273.7%) | June 30, 2026 |
| 15 | Dimensional Fund Advisors, Inc. | 1.71% | 2.2M | $155.5M | +182,334 (+8.9%) | June 30, 2026 |
| 16 | AQR Capital Management LLC | 1.56% | 2.0M | $141.6M | −511,792 (−20.2%) | June 30, 2026 |
| 17 | Jacobs Levy Equity Management, Inc. | 1.55% | 2.0M | $141.1M | −263,541 (−11.5%) | June 30, 2026 |
| 18 | Point72 Asset Management, L.P. | 1.42% | 1.9M | $129.4M | +1.9M (0.0%) | June 30, 2026 |
| 19 | Capital World Investors | 1.15% | 1.5M | $104.3M | +40,731 (+2.8%) | June 30, 2026 |
| 20 | T. Rowe Price Investment Management,Inc. | 0.97% | 1.3M | $88.5M | −12,428 (−1.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 10.4M shares and 9 cut 5.5M.
TXG top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.70% | 3.5M | $246.2M | −17,476 (−0.5%) | August 31, 2026 |
| 2 | ARK Innovation ETF | 2.35% | 3.1M | $213.6M | −655,459 (−17.7%) | September 30, 2026 |
| 3 | iShares Russell 2000 ETF | 2.33% | 3.0M | $211.9M | −34,944 (−1.1%) | September 30, 2026 |
| 4 | Vanguard Small Cap Index | 1.96% | 2.6M | $178.5M | +2,051 (+0.1%) | August 31, 2026 |
| 5 | ARK Genomic Revolution ETF | 1.89% | 2.5M | $172.0M | −43,038 (−1.7%) | September 30, 2026 |
| 6 | T. Rowe Price New Horizons | 1.82% | 2.4M | $165.5M | +239,278 (+11.2%) | August 31, 2026 |
| 7 | Fidelity Select Health Care | 1.64% | 2.1M | $148.9M | +519,105 (+32.2%) | August 31, 2026 |
| 8 | Fidelity Global Innovators Cl F | 1.55% | 2.0M | $141.0M | −38,328 (−1.9%) | June 30, 2026 |
| 9 | Fidelity Select Medical Tech and Devcs | 1.53% | 2.0M | $139.7M | — | August 31, 2026 |
| 10 | Strategic Advisers Fidelity US TtlStk | 1.27% | 1.7M | $115.8M | +4,941 (+0.3%) | August 31, 2026 |
| 11 | T. Rowe Price Integrated US Sm Gr Eq | 1.16% | 1.5M | $105.4M | −84,300 (−5.3%) | August 31, 2026 |
| 12 | Vanguard MStar Small Cap Growth Indx Inv | 1.13% | 1.5M | $102.4M | −4,822 (−0.3%) | August 31, 2026 |
| 13 | American Funds SMALLCAP World A | 1.11% | 1.5M | $101.5M | — | June 30, 2026 |
| 14 | T. Rowe Price Mid-Cap Value | 1.04% | 1.4M | $95.0M | +1.4M (0.0%) | August 31, 2026 |
| 15 | Fidelity Small Cap Index | 1.00% | 1.3M | $91.1M | +11,234 (+0.9%) | July 31, 2026 |
| 16 | Amova ARK Disruptive Innovation A USD | 0.98% | 1.3M | $89.1M | −510,635 (−28.6%) | August 31, 2026 |
| 17 | Amova ARK Pstv Chg Innovt P JPY Acc | 0.88% | 1.1M | $79.7M | −155,080 (−12.0%) | August 31, 2026 |
| 18 | iShares Russell 2000 Growth ETF | 0.84% | 1.1M | $76.6M | −1,387 (−0.1%) | September 30, 2026 |
| 19 | Fidelity VIP Mid Cap Initial | 0.76% | 989K | $69.1M | — | August 31, 2026 |
| 20 | Fidelity Advisor Health Care I | 0.74% | 964K | $67.4M | +9,561 (+1.0%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
TXG insider transactions
latest 15| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-14 | Serge Saxonov | Sell | $24.56 | 5,000 | $122,800 |
| 2026-03-24 | Serge Saxonov | Sell | $19.52 | 5,000 | $97,600 |
| 2026-03-23 | Serge Saxonov | Sell | $19.13 | 10,000 | $191,300 |
| 2026-02-23 | Adam Taich | Sell | $18.58 | 8,968 | $166,625 |
| 2026-02-23 | Benjamin J Hindson | Sell | $18.58 | 7,826 | $145,407 |
| 2026-02-23 | Serge Saxonov | Sell | $18.58 | 9,632 | $178,963 |
| 2025-11-24 | Adam Taich | Sell | $19.00 | 11,888 | $225,872 |
| 2025-11-24 | Benjamin J Hindson | Sell | $19.00 | 8,283 | $157,377 |
| 2025-11-24 | Serge Saxonov | Sell | $19.00 | 13,261 | $251,959 |
| 2025-08-22 | Adam Taich | Sell | $13.79 | 22,315 | $307,724 |
| 2025-08-22 | Benjamin J Hindson | Sell | $13.79 | 7,486 | $103,232 |
| 2025-08-22 | Serge Saxonov | Sell | $13.79 | 9,348 | $128,909 |
| 2025-05-22 | Adam Taich | Sell | $8.30 | 4,044 | $33,565 |
| 2025-05-22 | Benjamin J Hindson | Sell | $8.30 | 7,485 | $62,126 |
| 2025-05-22 | Serge Saxonov | Sell | $8.30 | 9,343 | $77,547 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
TXG shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns TXG
Institutional investors own 117.3% of 10x Genomics's shares and insiders 1.44%. The largest holder is FMR Inc with 13.53% of the shares (17.6M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 9 reduced their stake in the latest filings. Short interest is 17.30% of the float, or 5.24 days of average trading volume. The share count rose 959.0% since 2017.
Related: TXG analyst forecast, TXG key metrics. See the TXG stock overview for the latest quote and news.
TXG ownership FAQ
Who owns the most 10x Genomics stock?
The largest shareholders of 10x Genomics are FMR Inc (13.53%), BlackRock Inc (8.29%), ARK Investment Management LLC (7.68%), Vanguard Portfolio Management, LLC (5.36%), Quantinno Capital Management LP (4.20%).
What percentage of 10x Genomics is owned by institutions?
Institutions hold 117.3% of 10x Genomics's shares outstanding; insiders hold 1.44%.
Which funds own 10x Genomics?
The largest fund holders of 10x Genomics are Vanguard MStar Total Stk Mkt Idx Invest (2.70%), ARK Innovation ETF (2.35%), iShares Russell 2000 ETF (2.33%), Vanguard Small Cap Index (1.96%), ARK Genomic Revolution ETF (1.89%).
What is 10x Genomics's short interest?
15.4M shares of 10x Genomics were sold short, 17.30% of the float; at the average daily volume it would take 5.24 days to cover.
Are insiders buying or selling 10x Genomics?
Of the latest 15 reported insider transactions in 10x Genomics (since May 22, 2025), 0 were purchases and 15 were sales.
How many shares of 10x Genomics are outstanding?
10x Genomics has 120.2M shares outstanding, of which 118.2M are in the public float.